A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)

NCT01572948 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: roflumilast
DRUG: placebo

Sponsor

University of Alabama at Birmingham